Ionclinics

What Ionclinics does

Ionclinics (legal entity IONCLINICS & DEIONIC, S.L.) is a privately held Spanish medical device company headquartered in Alaquàs, Valencia, that designs, manufactures, and commercializes electromedical equipment for neuromodulation and percutaneous electrolysis therapy. Founded in the mid-2010s (firmographics list 2012; corporate-history sources cite 2015) and operating with 11–50 employees, the company's portfolio centers on the proprietary EPTE® (Electrólisis Percutánea Terapéutica) system — the first percutaneous electrolysis device to obtain CE sanitary marking — alongside bipolar EPTE variants, transcranial direct current stimulation devices (EPTE Bipolar tDCS, Home tDCS), the Yingchi TMS M-100 transcranial magnetic stimulator, an FMS functional magnetic stimulator, the EPTE Inertial Concept isoinertial training equipment, and NMP percutaneous neuromodulation protocols. The technology stack combines galvanic microcurrent application via acupuncture needles for tendinopathies with non-invasive brain stimulation for pain, mental health, and neurorehabilitation indications, all developed and produced under ISO 13485:2018 and EU MDR 2017/745 quality systems with additional ANVISA registration for Brazil.

The company monetizes through a mix of capital equipment sales (medical devices sold direct to clinicians and clinics), recurring professional training revenue (online tDCS courses at €225 and in-person EPTE certification programs delivered across Spain, Portugal, Mexico, Italy, and the Netherlands), and consumer-financed device purchases via 36-month installment plans. Its go-to-market is sales-led and event-driven: a multilingual direct-sales website (Spanish, English, Portuguese) with the ionclinicshop.com e-commerce storefront is paired with a 1,400+-clinic Official EPTE Center network spanning 25 countries, which functions simultaneously as a distribution channel, a certified-practitioner referral engine, and a customer-acquisition funnel — clinics that complete training then purchase devices and anchor local market presence. End customers include pain management units, mental health specialists, neurologists, physiotherapists, rehabilitation hospitals (e.g., Hospital Universitario La Paz, Vithas), and elite sports organizations (e.g., AS Roma).

Ionclinics' strategic posture emphasizes international scale (devices present in 40+ countries), method-based brand equity (EPTE® trademark, 30,000+ supporting scientific studies, 1,200+ trained physiotherapists), and incremental product innovation financed primarily through non-dilutive public grants — including CDTI funding for an AI-enabled portable tDCS device and AVI/EU FEDER co-funding for a 2025 competitiveness and EPTE 3 development program. The business remains a focused, niche European medtech OEM with global clinical reach but modest disclosed scale.

Name

Ionclinics

Legal name

IONCLINICS & DEIONIC, S.L.

Website

https://ionclinics.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Ionclinics is a Spanish medical device company that designs and manufactures neuromodulation and electrotherapy equipment — including the EPTE percutaneous electrolysis system, tDCS, TMS, and FMS devices — selling directly and through a 1,400+ certified clinic network to physiotherapists, pain specialists, hospitals, and rehabilitation providers across 40+ countries.

Ownership category

akta.pro rank

Product category

Electromedical Devices / Neuromodulation Equipment

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS) (HLAHAEAK)

akta.pro secondary industries

Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG), Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS) (HSADAIAC)

Keywords

• Percutaneous electrolysis therapy
• Neuromodulation medical devices
• Transcranial direct current stimulation
• Rehabilitation electrotherapy equipment
• Percutaneous neuromodulation devices

Headquarters

HQ city

Valencia

HQ country

Spain

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Ionclinics designs, manufactures, and commercializes medical devices for rehabilitation based on percutaneous electrolysis and neuromodulation. Revenue comes from selling devices such as EPTE System, EPTE Bipolar System, Home tDCS, TMS M-100, FMS, and EPTE Inertial Concept to healthcare providers and clinics.
2. Professional Training Courses: The company offers online and in-person training courses for healthcare professionals in therapeutic techniques and neuromodulation device usage. Courses include EPTE percutaneous electrolysis training and tDCS training. This creates recurring revenue and drives device adoption.
3. Financing Plans: Ionclinics offers financing plans up to 36 months for equipment purchases, making devices more accessible to smaller clinics and individual practitioners.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

Core offering

Ionclinics designs, manufactures, and commercializes electromedical devices for neuromodulation and percutaneous electrolysis therapy, including the EPTE System, EPTE Bipolar System, Home tDCS, EPTE Bipolar tDCS, TMS M-100, FMS, and EPTE Inertial Concept equipment. The company also provides online and in-person professional training courses for healthcare professionals (physiotherapists, doctors, rehabilitation specialists) in EPTE, tDCS, and other neuromodulation techniques, building a network of certified practitioners.

Product overview

Ionclinics offers a portfolio of neuromodulation and electrotherapy medical devices. The core offerings include the EPTE System and EPTE Bipolar System for percutaneous electrolysis therapy targeting tendinopathies; the EPTE Bipolar tDCS and Home tDCS for transcranial direct current stimulation; the TMS M-100 and FMS for transcranial and functional magnetic stimulation; and the EPTE Inertial Concept for isoinertial rehabilitation training. The company also provides associated techniques including tDCS, TMS, EPTE, and NMP (Percutaneous Neuromodulation), supported by professional training programs.

Differentiator

Problem solved

Functional benefit

Brands

• EPTE: EPTE (Electrólisis Percutánea Terapéutica / Percutaneous Therapeutic Electrolysis) is the company's flagship technique and brand for treating tendinopathies using galvanic microcurrents applied via acupuncture needles.

Products and services

• EPTE System
• EPTE Bipolar System Bipolar variant of the EPTE percutaneous electrolysis device with enhanced specifications for clinical use, providing bipolar capability for percutaneous electrolysis therapy. Targeted at clinical physiotherapy and rehabilitation practices.
• EPTE Bipolar tDCS Combined device integrating bipolar tDCS (transcranial direct current stimulation) capabilities with EPTE technology. Targeted at clinicians needing both percutaneous electrolysis and transcranial stimulation in one device.
• Home tDCS Portable tDCS (transcranial direct current stimulation) device designed for home use, enabling patients to receive neuromodulation treatments outside clinical settings under medical supervision.
• TMS M-100 Ultimate (Yingchi) Transcranial Magnetic Stimulation (TMS) device for non-invasive brain neuromodulation, imported and distributed by Ionclinics. Targeted at neurology, psychiatry, and pain management specialists.
• FMS (Functional Magnetic Stimulator) Functional magnetic stimulation device for therapeutic applications, used for muscle stimulation and rehabilitation therapy. Targeted at physiotherapy and rehabilitation clinics.
• EPTE Inertial Concept Isoinertial training equipment designed for sports rehabilitation and functional training. Emphasizes the eccentric phase of movement for muscle hypertrophy and injury recovery, featuring adjustable load types, movements, and power output. Targeted at sports medicine and rehabilitation centers.
• Professional Training Courses (EPTE and tDCS) Online and in-person training courses for healthcare professionals in therapeutic techniques and neuromodulation device usage. Courses include EPTE percutaneous electrolysis training and tDCS training (online tDCS course priced at 225€). Targeted at healthcare professionals including physiotherapists, doctors, and rehabilitation specialists.

Quantifiable outcome

• Average of 5 EPTE treatments for tendinopathy recovery depending on damage severity
• +3 more outcomes

Named customers7 records

Segments6 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

Two partnerships are on record, tiered minor and core.

• AS RomaminorStrategic or Co-development Partner · 6 July 2016AS Roma's medical-sanitary team received EPTE training at their official facilities in Trigoria, near Rome. The football club chose EPTE equipment for tissue regeneration and quick recovery of players from tendinopathies. Training was provided by Ionclinics instructors.
• EPTE Official Centers (1,400+)coreChannel Partner/ Reseller/ DistributorNetwork of over 1,400 officially certified centers across 25 countries that have purchased EPTE devices and completed official EPTE training. These centers represent the company's distribution and customer base, receiving branded materials, private website access, and official center certification.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Brainsway: Israel-based company commercializing deep TMS (dTMS) systems with FDA-cleared indications for depression, OCD, and smoking cessation; competes with Ionclinics' mental-health neuromodulation positioning but operates at a larger clinical scale with deeper US reimbursement access.
• Boston Scientific Neuromodulation: Large medical-device division of Boston Scientific focused on implantable spinal cord and deep brain stimulation systems. While Ionclinics targets non-invasive neuromodulation, Boston Sci competes indirectly for hospital neurology and pain-management budgets.
• DJO (Enovis): Large global orthopedic and rehabilitation medical-device company (formerly DJO Global) offering Chattanooga electrotherapy and rehabilitation equipment. Competes with Ionclinics across physiotherapy clinics but operates at a much broader portfolio scale.

Emerging players

• g.tec medical engineering: Austrian developer of brain-computer interface and neurotechnology products including recoveriX for stroke rehabilitation, comparable to Ionclinics in combining neuromodulation with rehabilitation use cases.
• EB Neuro: Italian neurophysiology and neuromodulation equipment manufacturer offering EEG, EMG, and stimulation systems, partially overlapping with Ionclinics' neurology and neurophysiology customer segment.

Direct peers

• Magstim: UK-based manufacturer of transcranial magnetic stimulation (TMS) systems for clinical and research applications, directly comparable to Ionclinics' TMS M-100 distribution and to neuromodulation practices in mental health and neurology.
• Soterix Medical: US-based developer of high-definition tDCS (HD-tDCS) and other non-invasive brain stimulation devices serving clinical and research markets, directly comparable to Ionclinics' Home tDCS and EPTE Bipolar tDCS offerings.
• Neuroelectrics: Barcelona-based developer of transcranial current stimulation (tDCS/tACS) devices (Starstim) and EEG-based neurodiagnostic systems, directly competing with Ionclinics in tDCS hardware for research and clinical neuromodulation, including home-use and AI-enabled platforms.
• Mectronic Medicale: Italian manufacturer of electrotherapy, ultrasound, and Tecar therapy devices for physiotherapy and sports medicine, directly competing with Ionclinics in rehabilitation hardware and offering similar percutaneous/electrolytic therapy modalities.

Regional players

• Neurosoft: Russian-origin manufacturer of neurophysiology and neuromodulation equipment (EEG, EMG, TMS) serving Eastern European and CIS markets, partially overlapping with Ionclinics in neuromodulation and neurodiagnostic product categories.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@ionclinics
• LinkedInlinkedin.com/company/epte-ionclinics
• Instagraminstagram.com/ionclinics
• Xx.com/ionclinics
• Facebookfacebook.com/centroIONCLINICS

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ionclinics